Retraction Watch

Weekend reads: ChatGPT ignores retractions; the ‘Swiss Cheese Model’ for flagging papers; plagiarism in the age of AI

The week at Retraction Watch featured:

Cardiology researcher in Italy up to 17 retractions, most for duplication
Authors asked Elsevier to retract papers in 2012. In the case of one paper, they’re still waiting
Hive mindfulness: Sleuths’ advice leads to retraction of paper on social connection
Top education researcher goes to court over plagiarism claims, university review
PLOS One slaps four papers with expressions of concern for overlapping control data

Our list of retracted or withdrawn COVID-19 papers is up past 500. There are more than 60,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? What about The Retraction Watch Mass Resignations List?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

PLOS One slaps four papers with expressions of concern for overlapping control data

Four papers from a team of researchers in Japan have received expressions of concern for overlap in control samples, data, study design and statistical analyses. The publisher of the articles says it has closed its investigation.

The notices were published in PLOS One from July 31 to August 3 to inform readers of “study design concerns” and to provide additional supplementary data. They also cite a pair of related papers in other journals for the same problems, but those articles remain unmarked.

Masaya Oki, a professor of applied chemistry and biotechnology at the University of Fukui in Japan, is the corresponding author on all six papers. Each discusses the effects of a different gene inhibitor on cataracts taken from rat eyes. While the authors used multiple methods to study these effects, the EOCs concern the results obtained using microarrays to compare lens samples.

Top education researcher goes to court over plagiarism claims, university review

A prominent education researcher in Australia is demanding compensation from a critic whose claims of plagiarism triggered the university to look into his work. Although the resulting examination of work by John Hattie, director of an education research institute at the University of Melbourne, ended without a finding of misconduct, the critic, Stephen Vainker, insists Hattie’s publications are rife with data errors and insufficient attribution.

Vainker came across “strange” citations in a paper by Hattie while studying for his doctorate in education management seven years ago. At first, he found 12 sentences lifted word-for-word, he said, from the original source about workplace management without proper citation. Among them were seven instances in which words such as “people” or “individuals” were changed to education-related words, such as “students.”

Then Vainker looked through Hattie’s most popular and influential text, Visible Learning, and its sequel, as well as his doctoral thesis, finding what he claimed were hundreds of data errors and examples of plagiarism.

Hive mindfulness: Sleuths’ advice leads to retraction of paper on social connection

A journal has retracted a 2025 paper on social media and anxiety after a reader raised questions about the data – and thanks to the mentorship of a sleuth or two.

The article appeared in 2023 in BMC Psychology, a Springer Nature title. The sole author was Li Sun, whose affiliation is listed as the School of Marxism at Zhoukou Vocational and Technical College, in China.

According to the abstract of the paper, the research explored “the impact of mindfulness-based mobile apps on university students’ anxiety, loneliness, and well-being.” Those apps were “Headspace, Calm, and Insight Timer” which “offer a range of mindfulness exercises and resources for users to explore.”

Authors asked Elsevier to retract papers in 2012. In one case, they’re still waiting.

Elsevier has retracted two papers for image duplication – 13 years after the authors alerted the journal to issues with the work.

The papers are the third and fourth retractions for a group of researchers in Ireland. The team had asked Elsevier journals to retract five papers in April 2012 — one of which is still in process.

The first two papers, published in Cancer Letters, were retracted in 2013.

Then last week, two more articles, published in the European Journal of Pharmacology (EJP), were retracted.

Cardiology researcher in Italy up to 17 retractions, most for duplication

A heart researcher from Italy has lost three papers because the articles duplicated work he had previously published. The retractions bring his tally to 17, all but one of which were for self-plagiarism.

The latest retractions for Renato De Vecchis were from the Journal of Clinical Medicine Research (JCMR). JCMR is published by Elmer Press and is not indexed in Clarivate’s Web of Science. De Vecchis most recently listed his affiliation as San Gennaro dei Poveri Hospital in Naples. He was previously at Elena d’Aosta, a health center in Naples. His published papers are all in cardiology research.

Richard Liu, the director and CEO of Elmer Press, told us JCMR “informed the related journals” of similarities between publications. He also said the journal never heard back from the authors but “since the contents overlapped are significant [sic],” the journal decided to retract the papers.

Weekend reads: Journal says no to RFK Jr.; another Microsoft quantum computing correction; ‘Journal Impact Nonsense’

Dear RW readers, can you spare $25?

The week at Retraction Watch featured:

Former lab tech earns federal funding ban years after leaving science
High school student who volunteered at NASA-sponsored lab gets retraction
Genomics pioneer earns first retraction for anti-aging gene therapy paper
Sage journal retracts nearly 50 papers for signs of paper mill activity
‘Tin Man Syndrome’ case plagiarized from hoax, sleuths say

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

‘Tin Man Syndrome’ case plagiarized from hoax, sleuths say

*A comparison of the images and an overlay, provided by a sleuth.*

On April Fools’ Day 10 years ago, radiologist Matt Skalski took part in a website’s annual challenge to prank the radiology community by posting the case of a man with “ectopia cordis interna,” or “Tin Man Syndrome.” Unlike the fictitious metal character from the Wizard of Oz, Skalski’s satirical patient had a heart — in his abdomen.

Now a group of researchers say they encountered the disease in real life, in a 22-year-old patient they claim has “no significant medical history.”

The researchers based in Iraq published their “rare case report” in Medicine in July.

Sage journal retracts nearly 50 papers for signs of paper mill activity

Sage has retracted four dozen papers from one of its journals for suspected paper mill activity.

The publisher started an investigation into the European Journal of Inflammation “after we noticed signs of papermill activity in one of the articles,” Laura West, a corporate communications and public affairs manager at Sage, told Retraction Watch.

The investigation found the papers “contain indicators of third-party involvement,” according to the retraction notice, published August 5. Sage and the editor of the journal decided to retract the articles due to “concerns around author contributions to these articles, as well as concerns around the integrity of the research process.”

Genomics pioneer George Church earns first retraction for anti-aging gene therapy paper

A paper coauthored by geneticist George Church has been retracted following an internal review at a university where several coauthors are based.

The article appeared in the Proceedings of the National Academy of Sciences in 2022. The work supports an anti-aging gene therapy developed by BioViva, a company for which Church serves as an adviser. The paper’s authors claim cytomegalovirus (CMV) can be a gene therapy vector for a treatment for “aging-associated decline” that can be inhaled or injected monthly.

The work has been cited 41 times, two of which are citations from corrections to the article, according to Clarivate’s Web of Science.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: